IG Farben

Bayer and Blackford Analysis Announce AI Platform Agreement in Radiology

Retrieved on: 
Tuesday, December 1, 2020
Medical devices, Health, Technology, Software, Radiology, Biotechnology, Articles, Science and technology, Computational neuroscience, Medical physics, Academic disciplines, Bayer, IG Farben, Artificial general intelligence, Radiology, Workflow, Artificial intelligence, Medical imaging

During RSNA, Bayer and Blackford Analysis announced an advancement in the use of AI in the imaging field; they entered into a development and license agreement to establish an artificial intelligence (AI) platform for radiology suites.

Key Points: 
  • During RSNA, Bayer and Blackford Analysis announced an advancement in the use of AI in the imaging field; they entered into a development and license agreement to establish an artificial intelligence (AI) platform for radiology suites.
  • Our agreement with Blackford Analysis reinforces our commitment to innovation in medical imaging.
  • The AI platform developed by Bayer and Blackford Analysis will provide access to a virtual marketplace through which healthcare professionals can obtain and manage various diagnostic imaging analysis applications, protocol management tools, departmental workflow tools and AI algorithms.
  • Under the terms of the agreement, Blackford Analysis will develop and provide platform technology for Bayer.

Former Chief Digital Officer of Bayer A.G. Joins Board of Maitri Health Technologies

Retrieved on: 
Tuesday, December 1, 2020
Articles, Health care, Health, Aspirin, Bayer, IG Farben, Leverkusen, Digital transformation, Pharmaceutical industry in China, Health technology

Federer is currently the US CEO of Huma Health, a global digital health company and an affiliate partner at Boston Millennia Partners, a venture capital firm focused on healthcare and technology.

Key Points: 
  • Federer is currently the US CEO of Huma Health, a global digital health company and an affiliate partner at Boston Millennia Partners, a venture capital firm focused on healthcare and technology.
  • "Jessica has been recognized as a leading health tech influencer and one of the world's top 100 Chief Digital Officers," said Andrew Morton, CEO of Maitri.
  • A former Chief Digital Officer of Bayer A.G., Federer led the worldwide digital transformation across Bayer's consumer health, pharmaceuticals, animal health and agriculture divisions.
  • Maitri Health Technologies Corp. (CSE:MTEC) is a global platform for healthcare supply security.

Bayer Bitterfeld to Optimize Asset Management with Infor EAM and Digital Twins

Retrieved on: 
Tuesday, November 24, 2020
Industries, Companies, IG Farben, Aspirin, Bayer, Leverkusen, Pharmaceutical industry in China, Business, Infor, EAM

MUNICH, Nov. 24, 2020 /PRNewswire/ --Infor today announced that Bayer pharmaceutical and life science group will deploy Infor EAM starting at its business site at Bitterfeld, Germany.

Key Points: 
  • MUNICH, Nov. 24, 2020 /PRNewswire/ --Infor today announced that Bayer pharmaceutical and life science group will deploy Infor EAM starting at its business site at Bitterfeld, Germany.
  • Bayer intends to enable more proactive facility, utility, and asset management operations to promote innovation, minimize costs, and maximize performance.
  • Learn more about Infor EAM: https://www.infor.com/products/eam
    Bayer Consumer Health and Bayer Pharmaceuticals produce over-the-counter and prescription drugs for 55 countries at its Bitterfeld site.
  • "By using Infor EAM, Bayer Bitterfeld expects to benefit from more transparency, control, and better decision-making options in production operations.

BASF reveals $14 Million transformation to Regina crop protection production facility

Retrieved on: 
Wednesday, November 18, 2020
BASF, IG Farben, Societates Europaeae, Regina, Saskatchewan, REGINA, Companies, Economy of Germany, Industries

Regina, SK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- BASF Canada Agricultural Solutions (BASF) unveiled today its modernized formulation, packaging and distribution facility in Regina, Saskatchewan.

Key Points: 
  • Regina, SK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- BASF Canada Agricultural Solutions (BASF) unveiled today its modernized formulation, packaging and distribution facility in Regina, Saskatchewan.
  • More than $14 million was invested in facility transformations, making it the divisions single biggest agriculture infrastructure investment in the last decade.
  • Major enhancements to BASFs Regina facility include upgrades to mechanical operations, automation systems, quality control and safety protocols and performance.
  • Expanded analytical capability in the lab to meet production requirements, allowing BASF to test, approve and record all products for quality assurance.

Bayer Fund Awards $3.9 Million in Grants throughout the United States

Retrieved on: 
Wednesday, November 18, 2020
Philanthropy, Health, Fitness & Nutrition, Fund Raising, Foundation, General Health, Pharmaceutical, Companies, Aspirin, Bayer, IG Farben, Leverkusen, Industries, Economy of Germany

Bayer Fund, a philanthropic arm of life sciences company Bayer, today awarded $3.9 million in grants to 80 charities and non-profit organizations throughout the United States, $300,000 of which is dedicated to supporting initiatives related to COVID-19.

Key Points: 
  • Bayer Fund, a philanthropic arm of life sciences company Bayer, today awarded $3.9 million in grants to 80 charities and non-profit organizations throughout the United States, $300,000 of which is dedicated to supporting initiatives related to COVID-19.
  • We are grateful to Bayer Fund for stepping forward in such a major way to help underwrite the CCNF program.
  • In the last five years, non-profit organizations across the United States have received more than $80 million from Bayer Fund.
  • Bayer Fund, a philanthropic arm of Bayer, is a nonprofit organization dedicated to strengthening the communities where Bayer customers and employees live and work by providing funding for food and nutrition, education and community development projects.

Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors

Retrieved on: 
Tuesday, November 17, 2020
Companies, Industries, Aspirin, Bayer, IG Farben, Leverkusen, Economy of Germany

Dr. Schwartz commented, I am excited to be joining the Board of Directors of Enlivex.

Key Points: 
  • Dr. Schwartz commented, I am excited to be joining the Board of Directors of Enlivex.
  • Dr. Schwartz brings significant experience in drug development in both the biotechnology and pharmaceutical industries.
  • Earlier in his career, Dr. Schwartz held a number of positions at Bayer Healthcare and Leo Laboratories.
  • Dr Schwartzis currently serves as a board member ofMereo Biopharma and LifeSci Acquisition Corp.
    Shai Novik, Executive Chairman of the Board of Enlivex, stated, We are excited to have Dr. Schwartz on our Board.

BASF named one of Canada's Top 100 Employers for the 7th consecutive year

Retrieved on: 
Monday, November 16, 2020
Articles, Labor, Employee relations, Economy, Human resource management, Workplace, IG Farben, Employee engagement, Organizational behavior, BASF, Employee voice

MISSISSAUGA, ON, Nov. 16, 2020 /CNW/ -BASF Canada has been recognized by Mediacorp as one of Canada's Top Employers for the seventh consecutive year.

Key Points: 
  • MISSISSAUGA, ON, Nov. 16, 2020 /CNW/ -BASF Canada has been recognized by Mediacorp as one of Canada's Top Employers for the seventh consecutive year.
  • Furthermore, BASF has been selected due to its extensive engagement focus to capture feedback from employees through surveys (internally called "Employee Voices").
  • An Employee Engagement Score derived from this survey has been included as a non-financial Key Performance Indicator in the company's scorecard.
  • BASF has implemented a "Giving Back" strategy in Canada focused on supporting its employees and the wider community through a number of initiatives.

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

Retrieved on: 
Thursday, November 12, 2020
Health, Chemicals, Plastics, Manufacturing, Genetics, Other Health, Pharmaceutical, Biotechnology, Companies, IG Farben, Industries, Aspirin, Bayer, Leverkusen, Economy of Germany, University of California, Berkeley, Bayer and Leaps by Bayer, Humboldt Fund, Metagenomi

Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully completed a USD 65 million Series A financing round and emerged from stealth mode today.

Key Points: 
  • Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully completed a USD 65 million Series A financing round and emerged from stealth mode today.
  • The Series A round was led by Leaps by Bayer and Humboldt Fund.
  • Leaps by Bayer is committed to advancing new breakthroughs in gene editing and is thrilled to partner with Metagenomi in its mission to discover tomorrows gene editing technologies.
  • Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture.

Food Emulsifiers Market: COVID-19 Business Continuity Plan | Evolving Opportunities with Archer Daniels Midland Co. and BASF SE | Technavio

Retrieved on: 
Tuesday, November 3, 2020
Food, Beverage, Retail, Physical sciences, Natural sciences, Chemistry, Colloidal chemistry, BASF, IG Farben, Societates Europaeae, ADM, Emulsion

The global food emulsifiers market size is expected to grow by USD 1.08 billion as per Technavio.

Key Points: 
  • The global food emulsifiers market size is expected to grow by USD 1.08 billion as per Technavio.
  • In addition, the multifunctionality of food emulsifiers is anticipated to boost the growth of the Food Emulsifiers Market.
  • Major Five Food Emulsifiers Companies:
    Archer Daniels Midland Co. has business operations under various segments, such as Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition.
  • BASF SE operates its business through various segments such as chemicals, materials, industrial solutions, surface technologies, nutrition and care, and agricultural solutions.

Bayer Signs Letter of Intent to Build New Distribution Center in Saxonburg, PA

Retrieved on: 
Tuesday, October 27, 2020
Radiology, Biotechnology, Other Manufacturing, General Health, Health, Fitness & Nutrition, Manufacturing, Other Health, Companies, IG Farben, Industries, Medical imaging, Radiology, Bayer, Supply chain management, Economy of Germany

ft. Distribution Center to support the ongoing growth of Bayers Radiology global business that supplies medical device products world-wide.

Key Points: 
  • ft. Distribution Center to support the ongoing growth of Bayers Radiology global business that supplies medical device products world-wide.
  • Its lease at the current distribution center, located in New Galilee, Pennsylvania is set to expire in March of 2022.
  • Coupled with automated conveyance systems, the new center will drive higher efficiencies and accuracy into the supply chain management process.
  • Bayer has approximately 1,300 employees in Pittsburgh that support the Radiology business and other global operations.